Free 2 day AUS and US shipping for orders above $200 • Register for an account to receive 20% off

BPC-157 / TB-500 Blend (10mg / 10mg)

$99.00

The BPC 157 and TB 500 blend offers synergistic benefits for tissue repair and regeneration. BPC 157 is a localized healing agent, promoting blood vessel growth and tissue-specific repair, while TB 500 is a systemic agent that enhances cell migration and mobilizes repair-related cells throughout the body. When used together, BPC 157 provides precise, targeted signals for tissue regeneration, and TB 500 ensures the efficient delivery of the necessary cellular resources. This combination of targeted signaling and widespread resource mobilization is believed to accelerate and enhance the overall healing process. It's important to note that these peptides are still in the research phase, and their combined use has not been approved for medical treatment.  

Synergistic Summary

  • Accelerates wound and tissue healing (muscle, tendon, ligament)
  • Enhances angiogenesis (new blood vessel growth) for repair
  • Reduces inflammation and fibrosis
  • Improves joint mobility and recovery from injuries

This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.

In Stock
Research Summary Description
Protective effects of BPC 157 on liver, kidney, and lung distant organ damage in rats with experimental lower-extremity ischemia–reperfusion injury Summary: This study on rats investigated the protective effects of BPC 157 against remote organ damage (liver, kidneys, and lungs) following a lower extremity ischemia-reperfusion injury. The findings demonstrated that BPC 157 significantly protected these distant organs by mitigating oxidative stress and reducing inflammation.

Citation: Budiša, A. V., Bilandžija, A. T., Vranješ, D., Vukojević, J., Tufan, M., Seiwerth, S., Sikiric, P. (2025). Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury. Medicina, 61(2), 291.
Multifunctionality and possible medical application of the BPC 157 peptide—literature and patent review Summary: This comprehensive review summarizes the biological activities and potential medical applications of BPC 157, based on existing literature and patents. It discusses the peptide's pleiotropic effects, including its role in tissue injury, inflammatory bowel disease, and central nervous system disorders, while also addressing its safety profile and the lack of human clinical trials.

Citation: Józwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals, 18(2), 185.
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs Summary: This preclinical study investigated the pharmacokinetics of BPC 157 in rats and dogs. It provides data on the peptide's absorption, distribution, metabolism, and excretion, which are essential for its potential future clinical development. The study found that BPC 157 has linear pharmacokinetic characteristics and is rapidly metabolized in vivo.

Citation: He, D., Hu, H., Cai, X., Xue, W., Shen, W., & Han, J. (2022). Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Drug Design, Development and Therapy, 16, 4193–4204.
Stable gastric pentadecapeptide BPC 157 and wound healing Summary: This article explores the role of BPC 157 in wound healing. It highlights the peptide's ability to promote angiogenesis and its cytoprotective properties, which contribute to its effectiveness in repairing various types of wounds, including those in the gastrointestinal tract, skin, and tendons.

Citation: Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Rokotov, D., Brcic, I., ... & Petek, M. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology, 12, 628920.
Utilizing developmentally essential secreted peptides such as thymosin beta-4 to remind the adult organs of their embryonic state—new directions in anti-aging regenerative therapies Summary: This review discusses the regenerative potential of Thymosin Beta-4 (the parent molecule of TB 500) and its ability to reactivate embryonic processes in adult tissues. It highlights the peptide's role in tissue repair, specifically mentioning its use in injured or infected eyes and in dermal wound healing.

Citation: Maar, K., Aichler, M., & Walz, M. (2021). Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies. Frontiers in Cell and Developmental Biology, 9, 660851.
BPC 157: An emerging therapeutic agent for neuroprotection and regeneration Summary: This review focuses on the neuroprotective and regenerative effects of BPC 157. It summarizes the peptide's beneficial effects in various preclinical models of central nervous system (CNS) disorders, including its ability to counteract brain damage and improve functional recovery after stroke.

Citation: Vukojević, J., Kolenc, D., Brcic, I., & Seiwerth, S. (2020). BPC 157: An Emerging Therapeutic Agent for Neuroprotection and Regeneration. Neural Regeneration Research, 15(11), 2097-2104.
Reawakening the regenerative potential of the heart with thymosin beta 4: A new strategy for cardiac repair Summary: This article explores the therapeutic potential of Thymosin Beta 4 (TB4) in cardiac repair. It discusses how TB4 can promote the regeneration of heart tissue and improve cardiac function after a myocardial infarction (heart attack) by stimulating the proliferation and migration of cardiovascular cells.

Citation: Smart, N., & Venter, D. J. (2020). Reawakening the Regenerative Potential of the Heart with Thymosin Beta 4: A New Strategy for Cardiac Repair. Current Heart Failure Reports, 17(2), 108–114.
Thymosin beta 4 and the eye: a review of basic and clinical studies Summary: This comprehensive review examines the role of Thymosin Beta 4 (TB4) in the eye, drawing from both basic science and clinical studies. It highlights the peptide's ability to promote corneal wound healing, reduce inflammation, and protect against various ocular diseases, suggesting its potential as a therapeutic agent for eye conditions.

Citation: Sosne, G., & Djalilian, A. R. (2020). Thymosin Beta 4 and the eye: a review of basic and clinical studies. Experimental Biology and Medicine, 245(15), 1417–1425.
Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair Summary: TB500, like its parent Tβ4, possesses anti-inflammatory abilities. It helps reduce swelling, redness, and pain associated with injuries by controlling the inflammatory response.

Citation: Siam Clinic Thailand. (n.d.). Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair.
Local and systemic peptide therapies for soft tissue regeneration: a narrative review Summary: This review identified various peptides, including those related to TB500, demonstrating efficacy in soft tissue repair. It noted that oral and intra-articular peptides showed distinct advantages in soft tissue regeneration, with intra-articular routes providing localized effects and oral routes offering systemic benefits.

Citation: Canapp Jr, S. O., Leasure, C. S., & Canapp, D. A. (2024). Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. Cells, 13(18), 1545.

Protective effects of BPC 157 on liver, kidney, and lung distant organ damage in rats with experimental lower-extremity ischemia–reperfusion injury

Summary: This study on rats investigated the protective effects of BPC 157 against remote organ damage (liver, kidneys, and lungs) following a lower extremity ischemia-reperfusion injury. The findings demonstrated that BPC 157 significantly protected these distant organs by mitigating oxidative stress and reducing inflammation.

Citation: Budiša, A. V., Bilandžija, A. T., Vranješ, D., Vukojević, J., Tufan, M., Seiwerth, S., Sikiric, P. (2025). Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury. Medicina, 61(2), 291.

Multifunctionality and possible medical application of the BPC 157 peptide—literature and patent review

Summary: This comprehensive review summarizes the biological activities and potential medical applications of BPC 157, based on existing literature and patents. It discusses the peptide's pleiotropic effects, including its role in tissue injury, inflammatory bowel disease, and central nervous system disorders, while also addressing its safety profile and the lack of human clinical trials.

Citation: Józwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals, 18(2), 185.

Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs

Summary: This preclinical study investigated the pharmacokinetics of BPC 157 in rats and dogs. It provides data on the peptide's absorption, distribution, metabolism, and excretion, which are essential for its potential future clinical development. The study found that BPC 157 has linear pharmacokinetic characteristics and is rapidly metabolized in vivo.

Citation: He, D., Hu, H., Cai, X., Xue, W., Shen, W., & Han, J. (2022). Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Drug Design, Development and Therapy, 16, 4193–4204.

Stable gastric pentadecapeptide BPC 157 and wound healing

Summary: This article explores the role of BPC 157 in wound healing. It highlights the peptide's ability to promote angiogenesis and its cytoprotective properties, which contribute to its effectiveness in repairing various types of wounds, including those in the gastrointestinal tract, skin, and tendons.

Citation: Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Rokotov, D., Brcic, I., ... & Petek, M. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology, 12, 628920.

Utilizing developmentally essential secreted peptides such as thymosin beta-4 to remind the adult organs of their embryonic state—new directions in anti-aging regenerative therapies

Summary: This review discusses the regenerative potential of Thymosin Beta-4 (the parent molecule of TB 500) and its ability to reactivate embryonic processes in adult tissues. It highlights the peptide's role in tissue repair, specifically mentioning its use in injured or infected eyes and in dermal wound healing.

Citation: Maar, K., Aichler, M., & Walz, M. (2021). Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies. Frontiers in Cell and Developmental Biology, 9, 660851.

BPC 157: An emerging therapeutic agent for neuroprotection and regeneration

Summary: This review focuses on the neuroprotective and regenerative effects of BPC 157. It summarizes the peptide's beneficial effects in various preclinical models of central nervous system (CNS) disorders, including its ability to counteract brain damage and improve functional recovery after stroke.

Citation: Vukojević, J., Kolenc, D., Brcic, I., & Seiwerth, S. (2020). BPC 157: An Emerging Therapeutic Agent for Neuroprotection and Regeneration. Neural Regeneration Research, 15(11), 2097-2104.

Reawakening the regenerative potential of the heart with thymosin beta 4: A new strategy for cardiac repair

Summary: This article explores the therapeutic potential of Thymosin Beta 4 (TB4) in cardiac repair. It discusses how TB4 can promote the regeneration of heart tissue and improve cardiac function after a myocardial infarction (heart attack) by stimulating the proliferation and migration of cardiovascular cells.

Citation: Smart, N., & Venter, D. J. (2020). Reawakening the Regenerative Potential of the Heart with Thymosin Beta 4: A New Strategy for Cardiac Repair. Current Heart Failure Reports, 17(2), 108–114.

Thymosin beta 4 and the eye: a review of basic and clinical studies

Summary: This comprehensive review examines the role of Thymosin Beta 4 (TB4) in the eye, drawing from both basic science and clinical studies. It highlights the peptide's ability to promote corneal wound healing, reduce inflammation, and protect against various ocular diseases, suggesting its potential as a therapeutic agent for eye conditions.

Citation: Sosne, G., & Djalilian, A. R. (2020). Thymosin Beta 4 and the eye: a review of basic and clinical studies. Experimental Biology and Medicine, 245(15), 1417–1425.

Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair

Summary: TB500, like its parent Tβ4, possesses anti-inflammatory abilities. It helps reduce swelling, redness, and pain associated with injuries by controlling the inflammatory response.

Citation: Siam Clinic Thailand. (n.d.). Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair.

Local and systemic peptide therapies for soft tissue regeneration: a narrative review

Summary: This review identified various peptides, including those related to TB500, demonstrating efficacy in soft tissue repair. It noted that oral and intra-articular peptides showed distinct advantages in soft tissue regeneration, with intra-articular routes providing localized effects and oral routes offering systemic benefits.

Citation: Canapp Jr, S. O., Leasure, C. S., & Canapp, D. A. (2024). Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. Cells, 13(18), 1545.

All content and product details on this website are provided solely for informational and educational purposes.

View Cart (0 items)

Your cart is empty

Start Shopping